annual CFF:
$5.70M-$785.79M(-99.28%)Summary
- As of today (June 29, 2025), LEGN annual cash flow from financing activities is $5.70 million, with the most recent change of -$785.79 million (-99.28%) on December 31, 2024.
- During the last 3 years, LEGN annual CFF has fallen by -$620.97 million (-99.09%).
- LEGN annual CFF is now -99.28% below its all-time high of $791.49 million, reached on December 31, 2023.
Performance
LEGN Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$667.00K+$1.00M(+300.30%)Summary
- As of today (June 29, 2025), LEGN quarterly cash flow from financing activities is $667.00 thousand, with the most recent change of +$1.00 million (+300.30%) on March 31, 2025.
- Over the past year, LEGN quarterly CFF has dropped by -$164.00 thousand (-19.74%).
- LEGN quarterly CFF is now -99.92% below its all-time high of $790.05 million, reached on June 30, 2023.
Performance
LEGN quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$5.53M-$164.00K(-2.88%)Summary
- As of today (June 29, 2025), LEGN TTM cash flow from financing activities is $5.53 million, with the most recent change of -$164.00 thousand (-2.88%) on March 31, 2025.
- Over the past year, LEGN TTM CFF has dropped by -$787.23 million (-99.30%).
- LEGN TTM CFF is now -99.53% below its all-time high of $1.17 billion, reached on June 30, 2023.
Performance
LEGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LEGN Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -99.3% | -19.7% | -99.3% |
3 y3 years | -99.1% | +2568.0% | -99.1% |
5 y5 years | -61.1% | -99.5% | -95.9% |
LEGN Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -99.3% | at low | -99.9% | +185.2% | -99.5% | +50.7% |
5 y | 5-year | -99.3% | at low | -99.9% | +185.2% | -99.5% | +50.7% |
alltime | all time | -99.3% | +127.8% | -99.9% | +109.3% | -99.5% | +50.7% |
LEGN Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $667.00K(-300.3%) | $5.53M(-2.9%) |
Dec 2024 | $5.70M(-99.3%) | -$333.00K(-107.8%) | $5.70M(-18.1%) |
Sep 2024 | - | $4.25M(+344.5%) | $6.96M(+89.4%) |
Jun 2024 | - | $955.00K(+14.9%) | $3.67M(-99.5%) |
Mar 2024 | - | $831.00K(-10.2%) | $792.76M(+0.2%) |
Dec 2023 | $791.49M(+109.4%) | $925.00K(-3.7%) | $791.49M(+0.2%) |
Sep 2023 | - | $961.00K(-99.9%) | $789.78M(-32.3%) |
Jun 2023 | - | $790.05M(<-9900.0%) | $1.17B(+209.0%) |
Mar 2023 | - | -$444.00K(-43.3%) | $377.51M(-0.1%) |
Dec 2022 | $377.98M(-39.7%) | -$783.00K(-100.2%) | $377.98M(-46.2%) |
Sep 2022 | - | $377.73M(>+9900.0%) | $702.32M(+115.6%) |
Jun 2022 | - | $1.01M(+3936.0%) | $325.74M(-48.0%) |
Mar 2022 | - | $25.00K(-100.0%) | $626.48M(-0.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $626.66M(+1.3%) | $323.56M(>+9900.0%) | $626.66M(+106.3%) |
Sep 2021 | - | $1.14M(-99.6%) | $303.76M(-2.7%) |
Jun 2021 | - | $301.75M(>+9900.0%) | $312.28M(-33.6%) |
Mar 2021 | - | $207.00K(-68.7%) | $470.33M(-24.0%) |
Dec 2020 | $618.88M(+4119.8%) | $661.00K(-93.2%) | $618.88M(+1.2%) |
Sep 2020 | - | $9.66M(-97.9%) | $611.54M(+1.6%) |
Jun 2020 | - | $459.80M(+209.1%) | $601.72M(+346.6%) |
Mar 2020 | - | $148.75M(-2326.9%) | $134.74M(+818.8%) |
Dec 2019 | $14.67M(+486.4%) | -$6.68M(+4237.7%) | $14.67M(-31.3%) |
Sep 2019 | - | -$154.00K(-97.9%) | $21.35M(-0.7%) |
Jun 2019 | - | -$7.18M(-125.0%) | $21.50M(-25.0%) |
Mar 2019 | - | $28.68M | $28.68M |
Dec 2018 | $2.50M | - | - |
FAQ
- What is Legend Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for Legend Biotech?
- What is Legend Biotech annual CFF year-on-year change?
- What is Legend Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Legend Biotech?
- What is Legend Biotech quarterly CFF year-on-year change?
- What is Legend Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for Legend Biotech?
- What is Legend Biotech TTM CFF year-on-year change?
What is Legend Biotech annual cash flow from financing activities?
The current annual CFF of LEGN is $5.70M
What is the all time high annual CFF for Legend Biotech?
Legend Biotech all-time high annual cash flow from financing activities is $791.49M
What is Legend Biotech annual CFF year-on-year change?
Over the past year, LEGN annual cash flow from financing activities has changed by -$785.79M (-99.28%)
What is Legend Biotech quarterly cash flow from financing activities?
The current quarterly CFF of LEGN is $667.00K
What is the all time high quarterly CFF for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from financing activities is $790.05M
What is Legend Biotech quarterly CFF year-on-year change?
Over the past year, LEGN quarterly cash flow from financing activities has changed by -$164.00K (-19.74%)
What is Legend Biotech TTM cash flow from financing activities?
The current TTM CFF of LEGN is $5.53M
What is the all time high TTM CFF for Legend Biotech?
Legend Biotech all-time high TTM cash flow from financing activities is $1.17B
What is Legend Biotech TTM CFF year-on-year change?
Over the past year, LEGN TTM cash flow from financing activities has changed by -$787.23M (-99.30%)